3 Feb 2023 11:50
3 February 2023
Oncimmune Holdings plc
("Oncimmune" or the "Company")
Notice of Annual General Meeting
Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, today gives notice that its Annual General Meeting ("AGM") will be held at 10:00am GMT on 27 February 2023 at the offices of Pinsent Masons LLP, 30 Crown Place, Earl Street, London, EC2A 4ES.
The Notice of AGM will be sent to shareholders today and can also be viewed on the "Investors" section of the Company's website at www.oncimmune.com.
For further information:
Oncimmune Holdings plc
Dr Adam M Hill, Chief Executive Officer
Matthew Hall, Chief Financial Officer
contact@oncimmune.co.uk
Singer Capital Markets (Nominated Adviser and Joint Broker)
Aubrey Powell, Harry Gooden, George Tzimas, James Fischer
+44 (0)20 7496 3000
WG Partners (Joint Broker)
David Wilson, Nigel Barnes, Erland Sternby
+44 (0)20 3705 9321
For more information, visit www.oncimmune.com
Oncimmune (ONC)